Plasma resistin levels were reduced from baseline with barnidipine + losartan treatment but were not reduced with telmisartan + hydrochlorothiazide treatment in patients with hypertension and type 2 DM [41]. The gene discussed is RETN; the disease is hypertensive disorder.